Specific and general HLA-DR binding motifs: Comparison of algorithms

Human Immunology

Volumn 61, Issue 3, 2000, Pages 266-278

  Borraás Cuesta, Francisco ^a   Golvano, Joseé Javier ^a   Garciía Granero, Marta ^a   Sarobe, Pablo ^a   Riezu Boj, Joseé Ignacio ^a   Huarte, Eduardo ^a   Lasarte, Juan Joseé ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Algorithm; Binding motif; Class II molecules; MHC; Prediction of binding; T cell determinant

Indexed keywords

AMINO ACID; CORE PROTEIN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; LEUCINE; PHENYLALANINE; TRYPTOPHAN; TYROSINE; VALINE;

ALGORITHM; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; HELPER CELL; HEPATITIS C VIRUS; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION;

ALGORITHMS; AMINO ACID MOTIFS; ANTIGEN PRESENTATION; BINDING SITES; HLA-DR ANTIGENS; HLA-DR1 ANTIGEN; HUMANS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0343775807     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00153-6     Document Type: Article

References (64)

1. Germain R.N., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol. 11:1993;403.
2. Guillet J.G., Lai M.Z., Briner T.J., Smith J.A., Gefter M.L. Interaction of peptide antigens and class II major histocompatibility complex antigens. Nature. 324:(6094):1986;260.
3. Babbitt B.P., Allen P.M., Matsueda G., Haber E., Unanue E.R. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature. 317:(6035):1985;359.
4. Buus S., Sette A., Colon S.M., Miles C., Grey H.M. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science. 235:(4794):1987;1353.
5. Sette A., Buus S., Colon S., Smith J.A., Miles C., Grey H.M. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature. 328:(6129):1987;395.
6. Sette A., Adorini L., Appella E., Colon S.M., Miles C., Tanaka S., Ehrhardt C., Doria G., Nagy Z.A., Buus S., et al. Structural requirements for the interaction between peptide antigens and I-Ed molecules. J Immunol. 143:(10):1989;3289.
7. Sette A., Buus S., Appella E., Smith J.A., Chesnut R., Miles C., Colon S.M., Grey H.M. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc Natl Acad Sci USA. 86:(9):1989;3296.
8. Busch R., Rothbard J.B. Detection of peptide-MHC class II complexes on the surface of intact cells. J Immunol Methods. 134:(1):1990;1.
9. Busch R., Strang G., Howland K., Rothbard J.B. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. Int Immunol. 2:(5):1990;443.
10. Jardetzky T.S., Gorga J.C., Busch R., Rothbard J., Strominger J.L., Wiley D.C. Peptide binding to HLA-DR1 a peptide with most residues substituted to alanine retains MHC binding. Embo J. 9:(6):1990;1797.
11. Roche P.A., Cresswell P. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR. J Immunol. 144:(5):1990;1849.
12. O'Sullivan D., Arrhenius T., Sidney J., Del Guercio M.F., Albertson M., Wall M., Oseroff C., Southwood S., Colon S.M., Gaeta F.C., Sette A. On the interaction of promiscuous antigenic peptides with different DR alleles Identification of common structural motifs. J Immunol. 147:(8):1991;2663.
13. Krieger J.I., Karr R.W., Grey H.M., Yu W.Y., O'Sullivan D., Batovsky L., Zheng Z.L., Colon S.M., Gaeta F.C., Sidney J., Albertson M., Del Guercio M.F., Chesnut R.W., Sette A. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. J Immunol. 146:(7):1991;2331.
14. Hill C.M., Hayball J.D., Allison A.A., Rothbard J.B. Conformational and structural characteristics of peptides binding to HLA-DR molecules. J Immunol. 147:(1):1991;189.
15. Brown J.H., Jardetzky T.S., Gorga J.C., Stern L.J., Urban R.G., Strominger J.L., Wiley D.C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 364:(6432):1993;33. [see comments].
16. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 329:(6139):1987;506.
17. Matsumura M., Fremont D.H., Peterson P.A., Wilson I.A. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science. 257:(5072):1992;927. [see comments].
18. Chicz R.M., Urban R.G., Lane W.S., Gorga J.C., Stern L.J., Vignali D.A., Strominger J.L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature. 358:(6389):1992;764.
19. Milich D.R. Synthetic T and B cell recognition sites implications for vaccine development. Adv Immunol. 45:1989;195.
20. Keene J.A., Forman J. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med. 155:(3):1982;768.
21. Leist T.P., Cobbold S.P., Waldmann H., Aguet M., Zinkernagel R.M. Functional analysis of T lymphocyte subsets in antiviral host defense. J Immunol. 138:(7):1987;2278.
22. Fayolle C., Deriaud E., Leclerc C. In vivo induction of cytotoxic T cell response by a free synthetic peptide requires CD4+ T cell help. J Immunol. 147:(12):1991;4069.
23. Lasarte J.J., Sarobe P., Gullon A., Prieto J., Borras Cuesta F. Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct. Cell Immunol. 141:(1):1992;211.
24. Shirai M., Pendleton C.D., Ahlers J., Takeshita T., Newman M., Berzofsky J.A. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. J Immunol. 152:(2):1994;549.
25. Rothbard J.B., Taylor W.R. A sequence pattern common to T cell epitopes. EMBO J. 7:(1):1988;93.
26. Margalit H., Spouge J.L., Cornette J.L., Cease K.B., Delisi C., Berzofsky J.A. Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J Immunol. 138:(7):1987;2213.
27. Stille C.J., Thomas L.J., Reyes V.E., Humphreys R.E. Hydrophobic strip-of-helix algorithm for selection of T cell-presented peptides. Mol Immunol. 24:(10):1987;1021.
28. Guillet J.G., Hoebeke J., Lengagne R., Tate K., Borras-Herrera F., Strosberg A.D., Borras-Cuesta F. Haplotype specific homology scanning algorithm to predict T-cell epitopes from protein sequences. J Mol Recognit. 4:(1):1991;17.
29. Hammer J., Takacs B., Sinigaglia F. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med. 176:(4):1992;1007.
30. Hammer J., Valsasnini P., Tolba K., Bolin D., Higelin J., Takacs B., Sinigaglia F. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell. 74:(1):1993;197.
31. Chicz R.M., Urban R.G., Gorga J.C., Vignali D.A., Lane W.S., Strominger J.L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med. 178:(1):1993;27.
32. Marshall K.W., Wilson K.J., Liang J., Woods A., Zaller D., Rothbard J.B. Prediction of peptide affinity to HLA DRB1*0401. J Immunol. 154:(11):1995;5927.
33. O'Sullivan D., Sidney J., Appella E., Walker L., Phillips L., Colon S.M., Miles C., Chesnut R.W., Sette A. Characterization of the specificity of peptide binding to four DR haplotypes. J Immunol. 145:(6):1990;1799.
34. O'Sullivan D., Sidney J., Del Guercio M.F., Colon S.M., Sette A. Truncation analysis of several DR binding epitopes. J Immunol. 146:(4):1991;1240.
35. Lasarte J.J., Garcia Granero M., Lopez A., Casares N., Garcia N., Civeira M.P., Borras Cuesta F., Prieto J. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. Hepatology. 28:(3):1998;815.
36. Merrifield R.B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc. 85:1963;2149.
37. Atherton E., Logan J.C., Sheppard R.C. Peptide synthesis II. Procedures for solid phase synthesis using N-fluorenyl methoxycarbonyl aminoacids on polyamide supports. Synthesis of substance P and of acyl carrier protein 65-74 decapeptide. J Chem Soc Perkin Trans. 1:1989;538.
38. Borras Cuesta F., Golvano J., Sarobe P., Lasarte J.J., Prieto I., Szabo A., Guillaume J.L., Guillet J.G. Insights on the amino acid side-chain interactions of a synthetic T-cell determinant. Biologicals. 19:(3):1991;187.
39. Kaiser E., Colescott R.L., Bossinger C.D., Cook P.I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem. 34:(2):1970;595.
40. Hammer J., Bono E., Gallazzi F., Belunis C., Nagy Z., Sinigaglia F. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J Exp Med. 180:(6):1994;2353.
41. Honeyman M.C., Brusic V., Stone N.L., Harrison L.C. Neural network-based prediction of candidate T-cell epitopes. Nat Biotechnol. 16:(10):1998;966.
42. Southwood S., Sidney J., Kondo A., del Guercio M.F., Appella E., Hoffman S., Kubo R.T., Chesnut R.W., Grey H.M., Sette A. Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol. 160:(7):1998;3363.
43. Sinigaglia F., Guttinger M., Kilgus J., Doran D.M., Matile H., Etlinger H., Trzeciak A., Gillessen D., Pink J.R. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature. 336:(6201):1988;778.
44. Panina Bordignon P., Tan A., Termijtelen A., Demotz S., Corradin G., Lanzavecchia A. Universally immunogenic T cell epitopes promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol. 19:(12):1989;2237.
45. Hickling J.K., Fenton C.M., Howland K., Marsh S.G., Rothbard J.B. Peptides recognized by class I restricted T cells also bind to MHC class II molecules. Int Immunol. 2:(5):1990;435.
46. Karr R.W., Yu W., Watts R., Evans K.S., Celis E. The role of polymorphic HLA-DR beta chain residues in presentation of viral antigens to T cells. J Exp Med. 172:(1):1990;273.
47. Gyllensten U., Sundvall M., Ezcurra I., Erlich H.A. Genetic diversity at class II DRB loci of the primate MHC. J Immunol. 146:(12):1991;4368.
48. Brown L.R., Nygard N.R., Graham M.B., Bono C., Braciale V.L., Gorka J., Schwartz B.D., Braciale T.J. Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition. J Immunol. 147:(8):1991;2677.
49. Kilgus J., Jardetzky T., Gorga J.C., Trzeciak A., Gillessen D., Sinigaglia F. Analysis of the permissive association of a malaria T cell epitope with DR molecules. J Immunol. 146:(1):1991;307.
50. Suhrbier A., Rodda S.J., Ho P.C., Csurhes P., Dunckley H., Saul A., Geysen H.M., Rzepczyk C.M. Role of single amino acids in the recognition of a T cell epitope. J Immunol. 147:(8):1991;2507.
51. Kropshofer H., Max H., Muller C.A., Hesse F., Stevanovic S., Jung G., Kalbacher H. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif. J Exp Med. 175:(6):1992;1799.
52. Harris P.E., Liu Z., Suciu-Foca N. MHC class II binding of peptides derived from HLA-DR 1. J Immunol. 148:(7):1992;2169.
53. Olson R.R., De Magistris M.T., Di Tommaso A., Karr R.W. Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide. J Immunol. 148:(9):1992;2703.
54. Newcomb J.R., Cresswell P. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers. J Immunol. 150:(2):1993;499.
55. Chaye H., Ou D., Chong P., Gillam S. Human T- and B-cell epitopes of E1 glycoprotein of rubella virus. J Clin Immunol. 13:(2):1993;93.
56. Panina-Bordignon P., Tan A., Termijtelen A., Demotz S., Corradin G., Lanzavecchia A. Universally immunogenic T cell epitopes promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol. 19:(12):1989;2237.
57. Feller D.C., de la Cruz V.F. Identifying antigenic T-cell sites. Nature. 349:(6311):1991;720.
58. Rothbard J.B., Gefter M.L. Interactions between immunogenic peptides and MHC proteins. Annu Rev Immunol. 9:1991;527.
59. Jensen P.E. Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH. J Exp Med. 174:(5):1991;1111.
60. Zeliszewski D., Golvano J.J., Gaudebout P., Dorval I., Freidel C., Gebuhrer L., Betuel H., Borras Cuesta F., Sterkers G. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320. J Immunol. 151:(11):1993;6237.
61. Boehncke W.H., Takeshita T., Pendleton C.D., Houghten R.A., Sadegh Nasseri S., Racioppi L., Berzofsky J.A., Germain R.N. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. J Immunol. 150:(2):1993;331.
62. Stern L.J., Brown J.H., Jardetzky T.S., Gorga J.C., Urban R.G., Strominger J.L., Wiley D.C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 368:(6468):1994;215.
63. Chou P.Y., Fasman G.D. Empirical predictions of protein conformation. Annu Rev Biochem. 47:1978;251.
64. Garnier J., Osguthorpe D.J., Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol. 120:(1):1978;97.